Comparison results
Add for comparison more than one drug or diagnosis.
| Results: Differences General | ✘Единственная артерия пуповины | |||||||||||
| Related research | Analogs | |||||||||||
| ||||||||||||
| Distinctive symptoms | ||||||||||||
| Register, to see more distinctive signs of diseases and studies | 100% | |||||||||||
| Register, to see more distinctive signs of diseases and studies | 94% | |||||||||||
| impaired arterial function | 81% | |||||||||||
| pregnancy complications | 74% | |||||||||||
| belly enlargement | 73% | |||||||||||
| angiopathy | 72% | |||||||||||
| postponed pregnancy | 72% | |||||||||||
| there are no complaints | 71% | |||||||||||
| arterial occlusion | 68% | |||||||||||
| multiple pregnancy | 66% | |||||||||||
| increased | 64% | |||||||||||
| history of surgery | 64% | |||||||||||
| myositis | 60% | |||||||||||
| late pregnancy | 56% | |||||||||||
| complications of childbirth | 56% | |||||||||||
| premature birth | 55% | |||||||||||
| vasculitis | 54% | |||||||||||
| increased motor activity | 51% | |||||||||||
| motor activity | 51% | |||||||||||
| 2 children | 49% | |||||||||||
| paranoia | 48% | |||||||||||
| early development | 48% | |||||||||||
| smokes | 47% | |||||||||||
| consequences of pregnancy | 47% | |||||||||||
| suspicion | 47% | |||||||||||
| vascular damage | 46% | |||||||||||
| childhood diseases | 40% | |||||||||||
| blood diseases | 40% | |||||||||||
| inflammation | 38% | |||||||||||
Instructions
Video 
- Introduce new diseases through 🔍 Search and input on the top panel using
- The table shows the most important distinguishing symptoms, tests and diagnoses related to the selected diseases.
- The higher the percentage, the more important this symptom is for the disease and vice versa. At 0%, we can say that this symptom never occurs in the disease.
- The list changes dynamically depending on the data of the current visit in the selection of therapy .
- Click on the percentageto see the suggestions from the original source.
- By using the service, you agree to user agreement.
